Page 0043

RESEARCH AND DEVELOPMENT

43 CANCER CONTROL 2021

1. Kim, H. S.; Sung, Y.-J.; Paik, S., Cancer Cell Line Panels Empower Genomics-Based Discovery

of Precision Cancer Medicine. Yonsei Med J 2015, 56 (5), 1186-1198.

2. Barretina, J.; Caponigro, G.; Stransky, N.; Venkatesan, K.; Margolin, A. A.; Kim, S.;

Wilson, C. J.; Lehár, J.; Kryukov, G. V.; Sonkin, D.; Reddy, A.; Liu, M.; Murray, L.; Berger,

M. F.; Monahan, J. E.; Morais, P.; Meltzer, J.; Korejwa, A.; Jané-Valbuena, J.; Mapa, F. A.;

Thibault, J.; Bric-Furlong, E.; Raman, P.; Shipway, A.; Engels, I. H.; Cheng, J.; Yu, G. K.;

Yu, J.; Aspesi, P., Jr.; de Silva, M.; Jagtap, K.; Jones, M. D.; Wang, L.; Hatton, C.; Palescandolo, E.; Gupta, S.; Mahan, S.; Sougnez, C.; Onofrio, R. C.; Liefeld, T.;

MacConaill, L.;

Winckler, W.; Reich, M.; Li, N.; Mesirov, J. P.; Gabriel, S. B.; Getz, G.; Ardlie, K.; Chan,

V.; Myer, V. E.; Weber, B. L.; Porter, J.; Warmuth, M.; Finan, P.; Harris, J. L.; Meyerson,

M.; Golub, T. R.; Morrissey, M. P.; Sellers, W. R.; Schlegel, R.; Garraway, L. A., The Cancer

Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature

2012, 483 (7391), 603-607.

3. Garnett, M. J.; Edelman, E. J.; Heidorn, S. J.; Greenman, C. D.; Dastur, A.; Lau, K. W.;

Greninger, P.; Thompson, I. R.; Luo, X.; Soares, J.; Liu, Q.; Iorio, F.; Surdez, D.; Chen, L.;

Milano, R. J.; Bignell, G. R.; Tam, A. T.; Davies, H.; Stevenson, J. A.; Barthorpe, S.; Lutz, S.

R.; Kogera, F.; Lawrence, K.; McLaren-Douglas, A.; Mitropoulos, X.; Mironenko, T.; Thi,

H.; Richardson, L.; Zhou, W.; Jewitt, F.; Zhang, T.; O'Brien, P.; Boisvert, J. L.; Price, S.;

Hur, W.; Yang, W.; Deng, X.; Butler, A.; Choi, H. G.; Chang, J. W.; Baselga, J.; Stamenkovic, I.; Engelman, J.

A.; Sharma, S. V.; Delattre, O.; Saez-Rodriguez, J.; Gray, N. S.; Settleman, J.;

Futreal, P. A.; Haber, D. A.; Stratton, M. R.; Ramaswamy, S.; McDermott, U.;

Benes, C. H., Systematic identification of genomic markers of drug sensitivity in cancer

cells. Nature 2012, 483 (7391), 570-575.

4. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.;

Langley, J.; Cronise, P.; Vaigro-Wolff, A.; et al., Feasibility of a high-flux anticancer drug

screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991,

83 (11), 757-66.

5. US Department of Health and Human Services Office of Minority Health Cancer and

African Americans. https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=4&lvlid=16.

6. Lisovicz, N.; Wynn, T.; Fouad, M.; Partridge, E. E., Cancer health disparities: what we

have done. Am J Med Sci 2008, 335 (4), 254-259.

7. Badal, S.; Aiken, W.; Morrison, B.; Valentine, H.; Bryan, S.; Gachii, A.; Ragin, C., Disparities in prostate cancer incidence and mortality rates:

Solvable or not? The Prostate 2020,

80 (1), 3-16.

8. Toles, C. A., Black men are dying from prostate cancer. Abnf j 2008, 19 (3), 92-5.

9. Badal, S.; Campbell, K. S.; Valentine, H.; Ragin, C., The need for cell lines from diverse

ethnic backgrounds for prostate cancer research. Nature Reviews Urology 2019, 16 (12),

691-692.

10. Tannock, I. F.; de Wit, R.; Berry, W. R.; Horti, J.; Pluzanska, A.; Chi, K. N.; Oudard, S.;

Théodore, C.; James, N. D.; Turesson, I.; Rosenthal, M. A.; Eisenberger, M. A., Docetaxel

plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J

Med 2004, 351 (15), 1502-12.

11. de Bono, J. S.; Oudard, S.; Ozguroglu, M.; Hansen, S.; Machiels, J. P.; Kocak, I.; Gravis,

G.; Bodrogi, I.; Mackenzie, M. J.; Shen, L.; Roessner, M.; Gupta, S.; Sartor, A. O., Prednisone plus cabazitaxel

or mitoxantrone for metastatic castration-resistant prostate

cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet

2010, 376 (9747), 1147-54.

12. Prakash, O.; Hossain, F.; Danos, D.; Lassak, A.; Scribner, R.; Miele, L., Racial Disparities

in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic

Factors. Front Public Health 2020, 8, 576964-576964.

13. DeSantis, C. E.; Fedewa, S. A.; Goding Sauer, A.; Kramer, J. L.; Smith, R. A.; Jemal, A.,

Breast cancer statistics, 2015: Convergence of incidence rates between black and white

women. CA Cancer J Clin 2016, 66 (1), 31-42.

14. Clarke, S.; Chin, S.; Dodds, L.; George, S.; Badal, S., Racial Disparities in Breast Cancer

Treatment: From Pre-clinical to Clinical. Submitted to Breast Cancer Research 2021,

Unpublished.

15. Siegel, R. L.; Miller, K. D.; Jemal, A., Cancer Statistics, 2017. CA Cancer J Clin 2017, 67

(1), 7-30.

16. Blom, E. F.; Ten Haaf, K.; Arenberg, D. A.; de Koning, H. J., Disparities in Receiving

Guideline-Concordant Treatment for Lung Cancer in the United States. Ann Am Thorac

Soc 2020, 17 (2), 186-194.

17. Williams, C. D.; Alpert, N.; Redding, T. S. t.; Bullard, A. J.; Flores, R. M.; Kelley, M. J.; Taioli, E., Racial Differences in Treatment

and Survival among Veterans and Non-Veterans

with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations.

Cancer Epidemiol Biomarkers Prev 2020, 29 (1), 112-118.

18. Blackman, E.; Ashing, K.; Gibbs, D.; Kuo, Y. M.; Andrews, A.; Ramakodi, M.; Devarajan,

K.; Bucci, J.; Jean-Louis, G.; Richards-Waritay, O.; Wilson, B.; Bowen, C.; Edi, E.; Tolbert, V.;

Noumbissi, R.; Cabral, D. N.; Oliver, J.; Roberts, R.; Tulloch-Reid, M.; Ragin, C.,

The Cancer Prevention Project of Philadelphia: preliminary findings examining diversity

among the African diaspora. Ethn Health 2021, 26 (5), 659-675.

19. Kim, E. S.; Tang, X.; Peterson, D. R.; Kilari, D.; Chow, C. W.; Fujimoto, J.; Kalhor,

N.; Swisher, S. G.; Stewart, D. J.; Wistuba, II; Siddik, Z. H., Copper transporter CTR1

expression and tissue platinum concentration in non-small cell lung cancer. Lung Cancer

2014, 85 (1), 88-93.

References

Index

  1. Page 0001
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028
  29. Page 0029
  30. Page 0030
  31. Page 0031
  32. Page 0032
  33. Page 0033
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038
  39. Page 0039
  40. Page 0040
  41. Page 0041
  42. Page 0042
  43. Page 0043
  44. Page 0044
  45. Page 0045
  46. Page 0046
  47. Page 0047
  48. Page 0048
  49. Page 0049
  50. Page 0050
  51. Page 0051
  52. Page 0052
  53. Page 0053
  54. Page 0054
  55. Page 0055
  56. Page 0056
  57. Page 0057
  58. Page 0058
  59. Page 0059
  60. Page 0060
  61. Page 0061
  62. Page 0062
  63. Page 0063
  64. Page 0064
  65. Page 0065
  66. Page 0066